Clinical Trial Update: Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for treatment of primary central nervous system lymphoma using R-IDARAM and intrathecal immunochemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• R-IDARAM

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Primary Central Nervous System Lymphoma | Phase 2, Phase 3 | Status: RECRUITING